Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

Pharmaceutical and health-tech companies are significantly expanding their research and development teams to foster innovation and meet str...

More than 500 companies are scheduled to release the earnings for the quarter and half-year ended September on Wednesday.

The digital clinic provides in-clinic consultation with at-home patient monitoring and care. A team of experts, including paramedics, nurse...

"The pharma industry is very bullish on growth right now. We are focusing on ramping up for new-age roles like product development speciali...

The under-performing pharma company's foray into a competitive services business like diagnostics may seem counter-intuitive, as Lupin has ...

Drug major Lupin on Thursday said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platfo...

Investors looking for safer bets and craving for returns in an uncertain market are taking shelter in these defensive bets.

ITC’s suite of interventions include providing medical infrastructure such as Covid care facilities for those mildly symptomatic and oxygen...

The company looks to build the IT infrastructure and supply chain required for pharma distribution.

The digital platform will provide the technological backbone to companies looking to build their own online B2B marketplace and, eventually...

McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, includ...

Three leading pharma companies announced their June quarter results towards the end of the week — each with different levels of performance...

Cipla beat expectations riding the demand for Covid medication. The Street is likely to push the stock to its record high hit in 2015. Whil...

As a start to digitize the patient journey in the overall healthcare space, Lupin is starting with ANYA to address queries related to diabe...

The drug firm is banking on the introduction of complex generics and biosimilars in the US to maintain its top five position in the market.

The 72,000-crore domestic drug market could grow between 11% and 13% in 2013, according to projections by pharma market research firms.